The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Compton, W. M.
* Articles by Colliver, J. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Compton, W. M.
* Articles by Colliver, J. D.
Related Collections
* AIDS/HIV
* Alcohol
* Amphetamines
* Cannabis
* Cocaine
* Nicotine
* Opioids
* Other Addictive Disorders
* Child Abuse
* Genetics
Am J Psychiatry 162:1494-1502, August 2005
© 2005 American Psychiatric Association


Reviews and Overviews

Developments in the Epidemiology of Drug Use and Drug Use Disorders

Wilson M. Compton, M.D., M.P.E., Yonette F. Thomas, Ph.D., Kevin P. Conway, Ph.D., and James D. Colliver, Ph.D.

The past 30 years of research on the epidemiology of drug use, drug use disorders, and related conditions, such as HIV, has provided major insight into these conditions. Drug use peaked in the late 1970s, decreased across the 1980s, increased in the 1990s, and has remained stable during the past few years. Within this broad pattern, specific epidemics of crack cocaine, amphetamines, club drugs (such as Ecstasy), heroin, and prescription opioids and associated epidemics of HIV and other infectious diseases have been identified and tracked. Besides major accomplishments in surveillance, the epidemiology of drug use and drug use disorders has traditionally focused on identifying risk factors at the individual (genetic factors, high-risk behaviors), family (child abuse), neighborhood (high availability of drugs), and societal (policies and laws) levels as domains of influence, not as components of interrelated processes. Research includes careful cross-sectional and longitudinal observational studies as well as clinical epidemiological experiments in which prevention interventions test specific etiological theories. Building on this background, the next challenges for the epidemiology of drug use and drug use disorders will be to link individual vulnerabilities with specific environmental factors by using multilevel methodological approaches. For example, what are the environmental factors that interact with individual vulnerabilities to produce drug addictions and drug consequences such as HIV? Research in genetic epidemiology has demonstrated the potential for studies of interactions of genetic and environmental factors. The field needs to focus on linking science with epidemiology to make progress in understanding these complex health conditions.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
W. M. Compton, Y. F. Thomas, F. S. Stinson, and B. F. Grant
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Drug Abuse and Dependence in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
Arch Gen Psychiatry, May 1, 2007; 64(5): 566 - 576.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
K. Poikolainen
Ecstasy and the antecedents of illicit drug use.
BMJ, April 8, 2006; 332(7545): 803 - 804.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org